Latest EVAX reports update at 2024-06-29: 2023 ∙ 2022 ∙ 2021

Evaxion Biotech A/S EVAX

$ 2.9 1.05%

Evaxion Biotech A/S Balance Sheet 2011-2024 | EVAX

Annual Balance Sheet Evaxion Biotech A/S

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-29.6 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt	-	-	2.21 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	326 K	303 K	314 K	20 K	36 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	3.4 M	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	17.6 M	13.7 M	7.73 M	4.93 M	1.72 M	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-50.4 M	-	-	-	-	-	-	-	-	-	-
Total Assets	12.9 M	22 M	40.2 M	12 M	11.1 M	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	5.58 M	13.2 M	32.2 M	5.83 M	9.56 M	7.43 M	-	-	-	-	-	-	-
Book Value	-4.73 M	8.3 M	32.4 M	7.04 M	9.36 M	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	32.4 M	7.04 M	9.36 M	-931 K	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Evaxion Biotech A/S

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	2.14 M	2.21 M	2.29 M	974 K	1.05 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	10 M	3.4 M	3.54 M	1.03 M	1.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	14.7 M	7.73 M	7.47 M	5.83 M	7.12 M	4.93 M	-	-	-	1.72 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-55.9 M	-50.4 M	-42.1 M	-37.5 M	-31.1 M	-27.3 M	-	-	-	-15.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	41.1 M	40.2 M	24.1 M	27.7 M	34.9 M	12 M	-	-	-	11.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	31.4 M	32.2 M	11.9 M	18.8 M	27 M	5.83 M	7.88 M	4.08 M	6.34 M	9.56 M	-	-	-	7.43 M	-	-	-	468 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	26.4 M	32.4 M	16.6 M	21.8 M	27.8 M	7.04 M	-	-	-	9.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	26.4 M	32.4 M	16.6 M	21.8 M	27.8 M	7.04 M	7.9 M	3.72 M	6.76 M	9.36 M	-	-	-	-931 K	-	-	-	2.55 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency